{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:17:38Z","timestamp":1793229458195,"version":"4.5.0"},"reference-count":49,"publisher":"American Society for Clinical Investigation","issue":"12","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"crossref","award":["U01HL108713"],"award-info":[{"award-number":["U01HL108713"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"crossref","award":["5T32GM008440-24"],"award-info":[{"award-number":["5T32GM008440-24"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,22]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Whether airspace biomarkers add value to plasma biomarkers in studying acute respiratory distress syndrome (ARDS) is not well understood. Mesenchymal stromal cells (MSCs) are an investigational therapy for ARDS, and airspace biomarkers may provide mechanistic evidence for MSCs\u2019 impact in patients with ARDS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>\n                      We carried out a nested cohort study within a phase 2a safety trial of treatment with allogeneic MSCs for moderate-to-severe ARDS. Nonbronchoscopic bronchoalveolar lavage and plasma samples were collected 48 hours after study drug infusion. Airspace and plasma biomarker concentrations were compared between the MSC (\n                      <jats:italic>n =<\/jats:italic>\n                      17) and placebo (\n                      <jats:italic>n =<\/jats:italic>\n                      10) treatment arms, and correlation between the two compartments was tested. Airspace biomarkers were also tested for associations with clinical and radiographic outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Compared with placebo, MSC treatment significantly reduced airspace total protein, angiopoietin-2 (Ang-2), IL-6, and soluble TNF receptor-1 concentrations. Plasma biomarkers did not differ between groups. Each 10-fold increase in airspace Ang-2 was independently associated with 6.7 fewer days alive and free of mechanical ventilation (95% CI, \u201312.3 to \u20131.0,\n                      <jats:italic>P =<\/jats:italic>\n                      0.023), and each 10-fold increase in airspace receptor for advanced glycation end-products (RAGE) was independently associated with a 6.6-point increase in day 3 radiographic assessment of lung edema score (95% CI, 2.4 to 10.8,\n                      <jats:italic>P =<\/jats:italic>\n                      0.004).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>MSCs reduced biological evidence of lung injury in patients with ARDS. Biomarkers from the airspaces provide additional value for studying pathogenesis, treatment effects, and outcomes in ARDS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT02097641.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>FUNDING<\/jats:title>\n                    <jats:p>National Heart, Lung, and Blood Institute.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1172\/jci.insight.148983","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T12:03:05Z","timestamp":1620734585000},"source":"Crossref","is-referenced-by-count":83,"title":["Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS"],"prefix":"10.1172","volume":"6","author":[{"given":"Katherine D.","family":"Wick","sequence":"first","affiliation":[{"name":"Departments of Medicine and Anesthesia and"},{"name":"Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6055-4644","authenticated-orcid":true,"given":"Aleksandra","family":"Leligdowicz","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA."},{"name":"Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjing","family":"Zhuo","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9429-4702","authenticated-orcid":true,"given":"Lorraine B.","family":"Ware","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, and"},{"name":"Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Matthay","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Anesthesia and"},{"name":"Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06296-9"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30177-2"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.6330"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201012-2090OC"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200803-419OC"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.10569"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318218669d"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200509-1477OC"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6758721","article-title":"Angiopoietin-2 levels as predictors of outcome in mechanically ventilated patients with acute respiratory distress syndrome","volume":"2017","author":"Tsangaris","year":"2017","journal-title":"Dis Markers"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2019.1581840"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60331"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201701-0170OC"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-211576"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0907996106"},{"key":"B15","article-title":"MSC extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS","author":"Silva","journal-title":"Eur Respir J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-204980"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30418-1"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00218.2020"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00263.2019"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201802-0356OC"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1504"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/stem.544"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-1-199501010-00003"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.5.1303"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00195.2012"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201206-0990OC"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201701-0107CP"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.119917"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00358.2013"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-04-1559"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025171"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201310-1892OC"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00381.2016"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050571"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.12.019"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2008.0253"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30369-8"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3685"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-2454"},{"issue":"2","key":"B40","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018769876","article-title":"Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS","volume":"8","author":"Hendrickson","year":"2018","journal-title":"Pulm Circ"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20994-x"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201208-1460OC"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5327-1"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00336.2015"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70097-9"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-211090"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-211280"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318228234b"},{"key":"B49"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/148983\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:48:40Z","timestamp":1779148120000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/148983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":49,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,6,22]]},"published-print":{"date-parts":[[2021,6,22]]}},"alternative-id":["10.1172\/jci.insight.148983"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.148983","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"article-number":"e148983"}}